Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories women in Global Management Roles (%) (%)
Form 10-K Item 1 (Human Capital Management)
Latest, FY2025
44.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
43.0% in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Women in Global Management Roles (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44.0% | +1.0 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2024 | Dec 31, 2024 | 43.0% | +1.0 pts | SEC Filing (0001628280-25-007110) ↗ |
| FY2023 | Dec 31, 2023 | 42.0% | +1.0 pts | SEC Filing (0001628280-24-005348) ↗ |
| FY2022 | Dec 31, 2022 | 41.0% | +1.0 pts | SEC Filing (0001628280-23-004026) ↗ |
| FY2021 | Dec 31, 2021 | 40.0% | +1.0 pts | SEC Filing (0001104659-22-025141) ↗ |
| FY2020 | Dec 31, 2020 | 39.0% | – | SEC Filing (0001104659-21-025751) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Women in Global Management Roles (%) (%), annual FY2020–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/emp-women-mgr-pct
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.